Skip to main content
Premium Trial:

Request an Annual Quote

The High-Tech Crystal Ball


Ever wonder why two market research groups can study the same field — say, the market for mass spectrometers in life science — and come up not only with vastly divergent predictions of how much it will be worth in five or 10 years, but also wildly different valuations of the market as it stands right now? Research Analyst A might say (with certainty) that this market will be worth $4.9 billion in 2010. Two days later, there’s always a Research Analyst B who issues a similar report pegging the same market value at, say, $500 million.

In the interest of bringing some of the values that have been so important to the systems biology community — namely, high-throughput performance and open access for everyone — Genome Technology introduces the Random Market Forecast Generator. Now you can feed in basic information, press a button, and (voilà!) get a market prediction of your very own. You can thank us later for all the time you’ll save not having to slog through all those “official” research reports.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.